These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 2859563)

  • 1. Immunochemical recognition of oxytocin by antiserum to L-prolyl-leucyl-glycine amide.
    Watkins WB; Peek JC
    Neurosci Lett; 1985 Mar; 54(2-3):283-8. PubMed ID: 2859563
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Radioimmunoassay of MIF-1/Tyr-MIF-1-like material in rat pineal.
    Kastin AJ; Lawrence SP; Coy DH
    Pharmacol Biochem Behav; 1980 Dec; 13(6):901-5. PubMed ID: 6111086
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of a radioimmunoassay for Pro-Leu-Gly-NH2 (PLG or MIF-I): evidence that PLG is not present in rat brain.
    Manberg PJ; Youngblood WW; Kizer JS
    Brain Res; 1982 Jun; 241(2):279-84. PubMed ID: 6125241
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition by L-prolyl-L-leucyl-glycinamide (PLG) of alpha-melanocyte stimulating hormone release from hypothalamic slices.
    Scimonelli T; Celis ME
    Peptides; 1982; 3(6):885-9. PubMed ID: 6132363
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The development and evaluation of a sensitive and specific radioimmunoassay for oxytocin in unextracted plasma.
    Robinson IC
    J Immunoassay; 1980; 1(3):323-47. PubMed ID: 6164694
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of the oxytocin fragment prolyl-leucyl-glycinamide on sexual behavior in the rat.
    Gorzalka BB; Luck KA; Tanco SA
    Pharmacol Biochem Behav; 1991 Feb; 38(2):273-9. PubMed ID: 1676168
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Radioimmunoassayable N-Tyr-MIF-1-like activity in rat brain is increased by pinealectomy.
    Kastin AJ; Lawrence SP; Coy DH
    Brain Res Bull; 1981 Dec; 7(6):697-702. PubMed ID: 6120031
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunochemical analysis of rabbit antibodies against oxytocin.
    Czernichow P; Dray F; Ronne J
    Immunochemistry; 1976 May; 13(5):389-94. PubMed ID: 939581
    [No Abstract]   [Full Text] [Related]  

  • 9. Synthesis and dopamine receptor modulating activity of unsubstituted and substituted triproline analogues of L-prolyl-L-leucyl-glycinamide (PLG).
    Baures PW; Pradhan A; Ojala WH; Gleason WB; Mishra RK; Johnson RL
    Bioorg Med Chem Lett; 1999 Aug; 9(16):2349-52. PubMed ID: 10476867
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative MSH release-inhibiting activities of tocinoic acid (the ring of oxytocin), and L-pro-L-leu-gly-NH 2 (the side chain of oxytocin).
    Bower A; Hadley ME; Hruby VJ
    Biochem Biophys Res Commun; 1971 Dec; 45(5):1185-91. PubMed ID: 5135504
    [No Abstract]   [Full Text] [Related]  

  • 11. Prolyl-leucyl-glycinamide shares some effects with oxytocin but decreases oxytocin levels.
    Petersson M; Uvnäs-Moberg K
    Physiol Behav; 2004 Dec; 83(3):475-81. PubMed ID: 15581670
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preparation and evaluation of antisera to oxytocin.
    Fingerová H; Slaninová J; Janousková M; Talas M
    Acta Univ Palacki Olomuc Fac Med; 1981; 101():68-72. PubMed ID: 6242697
    [No Abstract]   [Full Text] [Related]  

  • 13. C-terminal fragments of oxytocin (prolyl-leucyl-glycinamide and Z-prolyl-D-leucine) attenuate the development of tolerance to ethanol.
    Szabó G; Kovács GL; Székeli S; Baláspiri L; Telegdy G
    Acta Physiol Hung; 1987; 69(1):115-22. PubMed ID: 2884803
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect on brain monoamines in the rat of substituted and protected analogues of the oxytocin fragment, prolyl-leucyl-glycinamide following N-terminal substitution by homoproline.
    Szabó G; Kovács GL; Baláspiri L; Telegdy G
    Acta Physiol Hung; 1983; 62(1):25-33. PubMed ID: 6139932
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of MSH release-inhibiting elements in the neurointermediate lobe of the rat.
    Tilders FJ; van der Woude HA; Swaab DF; Mulder AH
    Brain Res; 1979 Aug; 171(3):425-35. PubMed ID: 38880
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Production of MSH-release-inhibiting hormone by a particulate preparation of hypothalami: mechanisms of oxytocin inactivation.
    Walter R; Griffiths EC; Hooper KC
    Brain Res; 1973 Oct; 60(2):449-57. PubMed ID: 4587290
    [No Abstract]   [Full Text] [Related]  

  • 17. Attenuated hypothalamic responses to α-melanocyte stimulating hormone during pregnancy in the rat.
    Ladyman SR; Augustine RA; Scherf E; Phillipps HR; Brown CH; Grattan DR
    J Physiol; 2016 Feb; 594(4):1087-101. PubMed ID: 26613967
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect on brain monoamines in the rat of substituted and protected analogues of the oxytocin fragment, prolyl-leucyl-glycinamide following N-terminal substitution by D- and L-pipecolic acid.
    Szabó G; Kovács GL; Baláspiri L; Telegdy G
    Acta Physiol Hung; 1986; 67(1):155-61. PubMed ID: 2871693
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prolyl-leucyl-glycine amide (PLG) and thyrotropin-releasing hormone (TRH): DOPA potentiation and biogenic amine studies.
    Plotnikoff NP
    Prog Brain Res; 1975; 42():11-23. PubMed ID: 730
    [No Abstract]   [Full Text] [Related]  

  • 20. Effect of the interaction between pro-leu-gly-NH2 and catecholaminergic drugs on MSH release from rat pituitaries incubated in vitro.
    Vivas A; Celis ME
    Neuroendocrinology; 1982; 35(3):150-4. PubMed ID: 6127639
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.